# Sirolimus as Therapeutic Approach to Uveitis

> **NCT00908466** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 30 (actual)

## Conditions studied

- Uveitis
- Intermediate Uveitis
- Posterior Uveitis
- Panuveitis

## Interventions

- **DRUG:** Sirolimus (rapamycin)
- **DRUG:** Sirolimus (rapamycin)

## Key facts

- **NCT ID:** NCT00908466
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-07
- **Final completion:** 2013-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00908466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00908466, "Sirolimus as Therapeutic Approach to Uveitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00908466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*